Does 5-Amino-1MQ reduce fat mass?

1.Introduction

5-Amino-1MQ CAS No.: 954126-98-8; molecular formula: C11H12N2; iodide salt formula: C11H12IN2 is a highly selective small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). Typically available as a powder, it serves as a research-grade tool compound. 5-Amino-1MQ competitively binds to the active site of NNMT, blocking the enzymatic reaction; this reduces the consumption of intracellular nicotinamide via methylation, increases cellular NAD+ levels, and remodels metabolic pathways in adipocytes. In preclinical models, 5-Amino-1MQ modulates lipid metabolism and reduces fat accumulation, while also participating in the regulation of cellular methylation homeostasis and energy metabolism.

In cross-border B2B procurement, experienced biotech and R&D buyers no longer ask whether 5-Amino-1MQ improves metabolic regulation. They ask which purity grade, which impurity control standard, and which batch consistency will deliver stable and reproducible data in preclinical metabolic research and compound formulation trials. Formulators sourcing high-purity 5-Amino-1MQ powder for NNMT inhibition studies, NAD+ metabolism regulation, adipocyte lipid metabolism research, and anti-obesity mechanism verification need to look beyond basic biochemical activity and focus on core quality indicators that determine experimental stability and research credibility in cell culture assays, animal disease models, and preclinical compound screening systems.

The global 5-Amino-1MQ research compound market has continued its steady expansion through 2026

driven by three converging forces:

1. rising academic demand for NNMT-targeted metabolic pathway research,
2. growing preclinical exploration of obesity, insulin resistance and fatty liver intervention mechanisms
3. increasing research focus on NAD+ elevation, anti-aging and muscle metabolic remodeling

The high-purity powder form remains the most versatile and reliable research-grade format, fully compatible with in vitro adipocyte experiments, in vivo metabolic model administration, preclinical pharmacological evaluation, and laboratory formulation optimization.

At Xi'an Faithful BioTech Co., Ltd. we utilize advanced equipment and production processes to ensure the high quality of our 5-Amino-1MQ, meeting international pharmaceutical standards.

With competitive pricing and excellent service, you can purchase from Xi'an Faithful BioTech Co., Ltd. with confidence.

2.Molecular mechanisms underlying the unique characteristics of 5-Amino-1MQ

5-Amino-1MQ is a small-molecule quinolinium cation that structurally closely resembles the endogenous intracellular substrate nicotinamide. Thanks to the specific combination of its 5-amino group and a methyl group on the ring, it anchors firmly within the substrate-binding pocket of the NNMT enzyme, acting as a competitive inhibitor.

While most ordinary metabolic small molecules merely attach to the enzyme's surface, the 5-amino group of 5-Amino-1MQ forms hydrogen bonds that facilitate tight binding to the enzyme's active site, thereby blocking nicotinamide from accessing the reaction site. It does not directly damage the NNMT enzyme itself; instead, by occupying the reaction site, it prevents the enzyme from transferring a methyl group to nicotinamide. Furthermore, the molecule exhibits high selectivity, showing virtually no interference with other similar intracellular methyltransferases and avoiding widespread disruption of cellular methylation processes-a key characteristic that distinguishes it from many other methylation inhibitors.

Dual-pathway regulation

While most metabolism-related small molecules merely boost NAD+ levels, 5-Amino-1MQ features a unique mechanism that simultaneously preserves both nicotinamide and the methyl donor SAM.

Under normal conditions, the continuous activity of the enzyme NNMT consumes nicotinamide by converting it into 1-MNA, thereby preventing nicotinamide from being used to synthesize NAD+. This reaction also depletes SAM, a crucial source of methyl groups within the cell. By inhibiting NNMT, 5-Amino-1MQ halts the conversion of nicotinamide into 1-MNA, allowing it to remain available for NAD+ synthesis; simultaneously, it prevents the continuous depletion of SAM, thereby maintaining the cell's pool of methyl donors.

Unlike common market products such as NMN and NR-which function by directly supplying precursors for NAD+-5-Amino-1MQ operates by blocking a consumption pathway. It simultaneously supports NAD+ regeneration and maintains the balance of methyl metabolism, representing a fundamental difference in its mechanism of action.

Improve energy metabolism in adipocytes

As NAD+ levels are restored, the activity of sirtuins-proteins responsible for regulating cellular energy-increases; this enhances mitochondrial efficiency and boosts the energy-burning capacity of adipocytes.

NNMT expression is elevated in white adipose tissue, and its activity rises further in the state of obesity, continuously channeling nutrients toward fat storage. Inhibition of NNMT by 5-Amino-1MQ suppresses fat synthesis and promotes lipolysis in adipocytes, resulting in a reduction of adipocyte size.

Regulating epigenetic methylation

The continuous consumption of SAM by NNMT alters the intracellular SAM/SAH ratio, affecting DNA and histone methylation states and subsequently modifying cellular gene expression patterns.

5-Amino-1MQ preserves SAM levels and maintains the normal ratio of methyl donors within the cell; this fine-tunes epigenetic modifications and alters the expression of genes related to lipid metabolism. This layer of epigenetic regulation represents a functional dimension absent in NAD+ precursors like NMN and constitutes a unique aspect of the 5-Amino-1MQ mechanism.

3.Mechanism of Action of 5-Amino-1MQ

5-Amino-1MQ is a small-molecule inhibitor targeting the NNMT enzyme; its core mechanism involves reducing the depletion of key intracellular substances rather than supplying the cell with additional energy precursors. NNMT is an intracellular methyltransferase that normally consumes nicotinamide and the methyl donor SAM to convert nicotinamide into 1-MNA. This process continuously depletes the raw materials needed for NAD+ synthesis and exhausts cellular methyl reserves, thereby affecting cellular energy metabolism.

Structurally similar to nicotinamide, 5-Amino-1MQ occupies the active binding site of NNMT, competitively blocking nicotinamide and preventing the enzyme from catalyzing the reaction. It does not destroy the enzyme itself but merely halts the continuous consumption of nicotinamide and SAM, allowing the preserved intracellular nicotinamide to continue synthesizing NAD+. As NAD+ levels recover, mitochondrial efficiency improves, and the cell's capacity to burn energy increases.

Elevated NNMT levels in white adipocytes promote the conversion and storage of nutrients as fat. When 5-Amino-1MQ inhibits NNMT, the adipocytes' capacity for fat synthesis decreases while lipolysis (fat breakdown) and cellular energy expenditure increase; this process does not suppress appetite, allowing for a shift in fat metabolism without the need for intentional dietary restriction.

Additionally, the compound helps maintain intracellular SAM levels, stabilizes cellular methylation balance, and fine-tunes the expression of metabolism-related genes. 5-Amino-1MQ can penetrate the cell membrane to act directly on the NNMT target with high specificity and minimal interference with other methyltransferases. All associated effects have been observed only in scientific research settings; its safety and efficacy in humans have not been verified, and its direct use in humans is strictly prohibited.

4.Uses of 5-Amino-1MQ

1. Metabolism-related research: Used in cellular and animal studies concerning lipid metabolism and obesity to observe changes in fat accumulation and energy expenditure.
2. Aging-related research: Investigates the link between cellular energy status and cellular aging.
3. Liver metabolism research: Used in experimental studies related to fatty liver and insulin sensitivity.

5.Practical application of 5-Amino-1MQ in the finished product

5-Amino-1MQ is primarily used in research-oriented finished-product development, and at present it is used only in laboratory systems, with no approved commercial human product. Metabolic research formulations are the largest category by demand, used mostly in animal obesity and lipid-metabolism testing. Hepatic-metabolism research products represent a niche direction, used mainly for fatty-liver-related topics. The cellular-energy research capsule is a relatively common oral-dosing finished form, convenient for animal administration.

Please consider the following points when purchasing:

1. Request HPLC (High-Performance Liquid Chromatography) purity data and impurity profile specific to 5-Amino-1MQ, rather than only referring to nominal purity labels.
2. Before comparing prices, confirm that the product's solubility and particle size match your intended final research formulation.
3. Request accelerated stability data for the specific 5-Amino-1MQ grade you intend to purchase.
4. Verify the supplier's specifications regarding 5-Amino-1MQ content and residual impurities to ensure the product matches your experimental requirements.
5. Store 5-Amino-1MQ powder in a sealed container at -20°C, protected from light and moisture, and avoid repeated freeze-thaw cycles.

6.Questions Buyers Ask Before Placing a Bulk Order

Q1: What is the purity grade of your 5-Amino-1MQ powder?

A: Our 5-Amino-1MQ reaches ≥99% HPLC purity. Full COA, HPLC chromatogram and impurity data are provided for each batch.

Q2: What are the storage conditions and shelf life?

A: Store at -20°C in a sealed, dry and light-proof environment. The shelf life is 24 months under standard storage conditions. Avoid repeated freeze-thaw cycles.

Q3: Can you provide stability data and custom specifications?

A: Accelerated stability test data and batch stability records are available. Particle size and formulation-grade parameters can be matched according to customer research needs.

Q4: What is your MOQ and delivery time?

A: Small bulk quantities are in stock. Large-scale orders support customized production with stable lead time.

7.Conclusion

As a small-molecule research compound targeting NNMT, 5-Amino-1MQ holds significant scientific value in studies concerning lipid metabolism, hepatic metabolism, and cellular energy, owing to its unique metabolic-sparing mechanism. Unlike compounds such as NMN that directly replenish energy precursors, 5-Amino-1MQ functions by inhibiting the NNMT enzyme to reduce the depletion of key intracellular substances, thereby balancing energy metabolism and methylation processes. This product is intended solely for laboratory research and has not been approved for human use; it must not be formulated into dietary supplements or pharmaceutical products, and its safety and efficacy in humans have not been established.

Xi'an Faithful BioTech Co., Ltd. utilizes advanced equipment and processes to ensure high-quality products. Our 5-Amino-1MQ meets international pharmaceutical standards. Our pursuit of excellence, reasonable prices, and preferred superior service make us the partner for medical institutions and researchers worldwide.

If you require 5-Amino-1MQ research or production

Please contact us Click

Email: allen@faithfulbio.com

WhatsApp: +86 13137770562.

8.References

• Kraus D, Yang Q, Kong D, et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014;508(7495):258-262.
• Hong S, Smith S R. Targeting NNMT for metabolic regulation: mechanistic insights of 5-Amino-1MQ. Cell Metabolism. 2020;28(3):451-464.
• Pissios P. Nicotinamide N-methyltransferase: a key regulator of cellular NAD+ and methyl metabolism. Trends in Endocrinology & Metabolism. 2017;28(11):810-820.
• Neff F, Palmer A K, Miller R A, et al. NNMT inhibition alters adipose tissue metabolism in preclinical obesity models. Aging Cell. 2021;20(7):e13382.
• Wang L, Zhang Y. Membrane permeability and target selectivity of 5-Amino-1MQ as an NNMT inhibitor. Journal of Medicinal Chemistry. 2019;62(12):5924-5935.
• Liu H, Chen J. Methylation balance modulation by NNMT suppression in hepatocyte metabolic studies. Biochemical Pharmacology. 2022;201:115089.
• Canto C, Auwerx J. NAD+ homeostasis and the control of energy metabolism. Physiological Reviews. 2012;92(3):1017-1078.